# US 2016/0250376 A1 · Cement products and methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250376 A1
- Document ID: US20160250376A1
- Status: Published application
- Kind: A1
- Application number: 15/149,986
- Filed: 2016-05-09
- Published: 2016-09-01
- Earliest claimed: 2007-08-28
- Assignees: Pioneer Surgical Technology, Inc.
- Applicants: Pioneer Surgical Technology, Inc.
- Inventors: Juchui Ray Lin; Edward S. Ahn; Brian M. Schlossberg
- Web page: https://patentgrep.com/patent/US20160250376A1

## CPC

- A61L 24/06: obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)}
- A61K 6/838: Phosphorus compounds, e.g. apatite
- A61K 6/884: comprising natural or synthetic resins
- A61K 6/887: Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 24/02: containing inorganic materials
- A61L 24/04: containing macromolecular materials
- A61L 24/046: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}
- A61L 2300/112: Phosphorus-containing compounds, e.g. phosphates, phosphonates
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/12: for dental implants or prostheses
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component. The first component comprises a polymerizable resin comprising ethylenic unsaturated double bond, a suitable glycidyl group and/or a suitable isocyanate group. The second component includes a compound comprising more than one type of amine selected from the group consisting of primary amine, secondary amines, tertiary amines and quaternary amines. Alternatively, the second component includes a compound comprising a suitable mercapto (SH—) group, a hindered amine or a dimethylthiotoluenediamine (DMTDA). Optionally, the cement product includes a filler and/or a bioactive component to promote bone formation.

## Claims

### Claim 1

A method of forming a cement product, the method comprising:
(i) mixing a first component and a second component, wherein
the first component comprises a polymerizable resin that comprises two or more acrylate groups; and
the second component comprises a compound selected from the group consisting of (i) a compound that includes more than one type of amine selected from the group consisting of a primary amine, a secondary amine, a tertiary amine, and a quaternary amine, (ii) a compound that includes a mercapto group, (iii) a compound that includes a hindered amine, (iv) a dimethylthiotoluenediamine (DMTDA) compound, and (v) a combination of two or more compounds of (i)-(iv), and
wherein the first component, the second component, or both the first and second components comprise a bioceramic filler;
(ii) allowing the first component and second component to react with each other in a polymerization reaction at room temperature to produce an orthopedic or dental cement having a compressive strength of about 20 MPa to about 250 MPa, and
(iii) allowing the polymerization reaction mixture to set at about 37° C.,
wherein the polymerization reaction mixture does not exceed a maximum temperature of 60° C. for a period of one minute.

### Claim 2 (depends on 1)

The method of claim 1, wherein the polymerization reaction mixture does not exceed a maximum temperature of 50° C. for a period of one minute.

### Claim 3 (depends on 1)

The method of claim 1, wherein a dry-to-touch finish of the orthopedic or dental cement is achieved in about 30 minutes or less.

### Claim 4 (depends on 1)

The method of claim 1, wherein a dry-to-touch finish of the orthopedic or dental cement is achieved in about 15 minutes or less.

### Claim 5 (depends on 1)

The method of claim 1, wherein a dry-to-touch finish of the orthopedic or dental cement is achieved in about 10 minutes or less.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein
the first comprises a polymerizable resin that includes two or more acrylate groups; and
the second component comprises a biocompatible formulation of a naturally occurring polyamine found in, a derivative of a naturally occurring polyamine found in humus, or a combination thereof.

### Claim 9 (depends on 8)

The method of claim 8, wherein the second component comprises a biocompatible formulation comprising (a) a naturally occurring polyamine found in humus selected from the group consisting of putrescine (1,4-diaminobutane), spermidine, and spermine, (b) a derivative of putrescine (1,4-diaminobutane), a derivative of spermidine, or a derivative of spermine, or (c) a combination of two or more of (a) and (b).

### Claim 10 (depends on 9)

The method of claim 9, wherein the derivative of a naturally occurring polyamine is a naturally occurring polyamine blended or grafted with (a) one or more amino acids selected from the group consisting of L-phenylalanine, L-tryptophan, L-arginine, L-cysteine, L-cysteine, L-tyrosine, L-lysine, L-histidine, (b) one or more derivatives of selected from the group of L-phenylalanine, L-tryptophan, L-arginine, L-cysteine, L-cysteine, L-tyrosine, L-lysine, and L-histidine derivatives, or (c) a combination of two or more of the amino acids or derivatives thereof of (a) and (b).

### Claim 11 (depends on 1)

The product of claim 1, wherein the first component comprises a compound selected from the group consisting of bisphenol A glycerolate di(meth)acrylate, non-alkoxylated trimethylpropane tri(meth)acrylate (TMPT(M)A), ethoxylated (15) TMPT(M)A, ethoxylated (9) TMPT(M)A, ethoxylated (6) TMPTA, ethoxylated (3) TMPTA, propoxylated (3) TMPT(M)A, propoxylated (6) TMPT(M)A, propoxylated (5) glycerol ethoxylated bisphenol-A-triacrylate, ethoxylated (2) bisphenol A diacrylate (E(2)BisDA), ethoxylated (4) bisphenol A diacrylate (E(4)BisDA), trimethylolpropane benzoate diacrylate, pentaerythritol triacrylate, pentaerythritoltetraacrylate, butanedioldiacrylate, hexanedioldiacrylate and mixtures thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein the first component comprises trimethylolpropane triacrylate.

### Claim 13 (depends on 1)

The method of claim 1, wherein the first component comprises non-alkoxylated pentaerythritol triacrylate.

### Claim 14 (depends on 1)

The method of claim 1, wherein the first component comprises E(2)BisDA, E(4)BisDA, trimethylolpropane benzoate diacrylate, 1,4-butandioldiacrylate, 1,3-butanedioldiacrylate, 1,6-hexanediol diacrylate, or a mixture thereof.

### Claim 15 (depends on 1)

The method of claim 1, wherein the second component further comprises one or more synthetic polyamine selected from the group consisting of 2-methyl-1,5-pentamethylenediamine, 2-ethyl-1,3-trimethylenediamine, N-(3-Aminopropyl)-1,3-propanediamine, diethylenetriamine (DETA), triethylenetetramine (TETA), and polyethyleneimine (PEI).

### Claim 16 (depends on 1)

The method of claim 1, wherein
the first component comprises trimethylolpropane triacrylate; and
the second component comprises a polyamine selected from the group consisting of putrescine (1,4 diaminobutane), spermidine, spermine, 2-methyl-1,5-pentamethylenediamine, or a combination thereof.

### Claim 17 (depends on 16)

The method of claim 16, wherein
the first component comprises bisphenol A diglycidyl ether 33-67% w/w, trimethylolpropane triacrylate 33-67% w/w, and, optionally, trimethylolpropane benzoate diacrylate 0-33% w/w; and
the second component comprises a mixture of spermidine 33-100% w/w and, optionally, 2-methyl-1,5-pentamethylenediamine 0-67% w/w.

### Claim 18 (depends on 1)

The method of claim 1, wherein
the first component comprises trimethylolpropane triacrylate; and
the second component comprises a polyamine selected from the group consisting of putrescine (1,4 diaminobutane), spermidine, and spermine, 2-methyl-1,5-pentamethylenediamine, 2-ethyl-1,3-trimethylenediamine, or a combination thereof.

### Claim 19 (depends on 18)

The method of claim 18, wherein
the first component comprises sorbitol polyglycidyl ether 0-40% w/w, trimethylolpropane triacrylate 0-30% w/w, and 1,4-butanediol 0-20% w/w such that the weight percent of sorbitol polyglycidyl ether, the weight percent of trimethylolpropane triacrylate, and the weight percent of 1,4-butanediol total 100% w/w; and
the second component comprises spermidine 20-100% w/w and, optionally, a second polyamine compound selected from the group consisting of 2-methyl-1,5-pentamethylenediamine and 2-ethyl-1,3-trimethylenediamine, 0-80% w/w.

### Claim 20

(canceled)

### Claim 21 (depends on 1)

The method of claim 1, wherein the filler comprises tricalcium phosphate (α-TCP, β-TCP), hydroxyapatite, calcium phosphate, or a mixture thereof.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28

(canceled)

### Claim 29 (depends on 1)

The method of claim 1, wherein the first component and/or the second component further comprises an initiator or catalyst.

### Claim 30 (depends on 29)

The method of claim 29, wherein the initiator is a photoinitiator selected from the group consisting of a quinone photoinitator, 2-benzyl-2-(dimethylamino)-4′-morpholino-butyrophenone, or mixtures of 2-hydroxyethy-2-methyl-1-phenyl-1-propanone, and diphenyl (2,4,6-trimethylbenzyl) phosphine oxide.

### Claim 31 (depends on 29)

The method of claim 29, wherein the first component and/or the second component comprises a catalyst and the catalyst comprises a benzoyl peroxide (BPO) catalyst or an amine-containing catalyst.

### Claim 32

(canceled)

### Claim 33

(canceled)

### Claim 34 (depends on 1)

The method of claim 1, wherein the first component and the second component are each packaged in (i) a separate chamber of the same container or (ii) a separate container.

### Claim 35 (depends on 34)

The method of claim 34, wherein (i) the same container is adapted for injecting cement formed from the first and second component or (ii) each separate container is adapted for injecting cement formed from the first and second component.

### Claim 36

(canceled)

### Claim 37

(canceled)

### Claim 38

(canceled)
